Daily Headlines

PUTTING BREAKING MEDICAL NEWS INTO PRACTICE^™

Tuesday March 04, 2008

TODAY'S HEADLINES
Add us to your address book or trusted sender list to help ensure delivery.

Did you know that you can earn CME/CE credit by reading our news reports? Look for the CME designation after the article title.

No-Nonsense Device Weans Kids’ TV and Computer Use and Fights Weight

BUFFALO, N.Y. -- Reducing kids’ TV and computer consumption with the aid of an electric governor that is impervious to pleading and wheedling may help overweight children shed pounds, researchers here said. full story

http://www.medpagetoday.com/Pediatrics/Obesity/dh/8577

Survey How Should Physicians Be Paid?

Presidential candidate John McCain?s health adviser says McCain believes physicians should be paid based on patient outcomes, not fee-for-service, which ?pays based on volume alone.? Vote

OTHER MEDPAGE TODAY EXTRAS

Blogs

Campaign '08

Multimedia

Practice Pointers

Misuse of Prescription Medications Associated with Other Drug Abuse

ANN ARBOR, Mich. -- College students who use one or more of four classes of medications prescribed for someone else are more likely to abuse other drugs, a survey here showed. full story

http://www.medpagetoday.com/PrimaryCare/PreventiveCare/dh/8583

Tamoxifen Efficacy in Bipolar Mania Gets Additional Backing

IZMIR, Turkey -- More evidence has emerged suggesting that protein kinase C inhibitors may be effective in the manic phase of bipolar disorder, researchers here said. full story

http://www.medpagetoday.com/Psychiatry/BipolarDisorder/dh/8582

Genetic Region Linked to Breast Cancer Risk

NEW YORK -- A genetic variation in a region of chromosome six appears to increase the risk of breast cancer by about 40%, researchers here said. full story

http://www.medpagetoday.com/HematologyOncology/BreastCancer/dh/8580

Stress, Not Depression, Linked to Stroke

CAMBRIDGE, England -- Psychological distress is associated with increased risk of both fatal and nonfatal stroke, but major depressive disorder does not appear to be a risk factor, a large, prospective study found. full story

http://www.medpagetoday.com/Cardiology/Strokes/dh/8581

Depression for Men in Later Life Associated with Low Free Testosterone

PERTH, Australia -- A jolt of free testosterone might help older men shake off the blues, suggested investigators here who linked low levels in those ages 71 to 89 with a greater risk of depression. full story

http://www.medpagetoday.com/Psychiatry/Depression/dh/8578

Still More Fentanyl Pain Patches Recalled
MORRISTOWN, N.J., -- Actavis, a maker of fentanyl patches, has expanded a recall to include all of its fentanyl pain patches sold in the United States, the company announced. full story

http://www.medpagetoday.com/ProductAlert/Prescriptions/dh/8572

Symptoms of Eating Disorders Common in Narcolepsy

NIJMEGEN, The Netherlands -- Half of the patients with narcolepsy in a case-control study reported a persistent craving for food and binge eating, researchers here reported. full story

http://www.medpagetoday.com/Psychiatry/sleepdisorders/dh/8570

Arsenic-Labeled Antibody Shows Tumor Imaging Potential

DALLAS -- Tumor imaging with an arsenic-labeled antibody has demonstrated potential for revealing hard-to-find lesions and monitoring treatment progress, results of a study in rats suggest. full story

http://www.medpagetoday.com/HematologyOncology/OtherCancers/dh/8568

Survey Shows 37% Prevalence of Pelvic Floor Disorders

SAN DIEGO -- More than a third of community-dwelling women have a pelvic floor disorder, and most have more than one disorder, according to the results of a survey here. full story

http://www.medpagetoday.com/OBGYN/UrinaryIncontinence/dh/8557

FDA Approves Desvenlafaxine (Pristiq) for Major Depression
MADISON, N.J. -- The FDA has approved desvenlafaxine (Pristiq), a serotonin-norepinephrine reuptake inhibitor (SNRI) for use in adults for major depressive disorder, according to an announcement by Wyeth. full story

http://www.medpagetoday.com/ProductAlert/Prescriptions/dh/8567

FDA Rejects Olanzapine (Zyprexa) Depot for Schizophrenia
INDIANAPOLIS -- The FDA said there was not enough evidence to approve a long-acting injectable formulation of olanzapine (Zyprexa) for the treatment of schizophrenia in adults, according to a statement issued by Eli Lilly and Company. full story

http://www.medpagetoday.com/ProductAlert/Prescriptions/dh/8566

ADHD Meds Aren’t ’Gateway’ Drugs

BOSTON -- Stimulant drugs for attention deficit hyperactivity disorder appear to have no long-term impact on the risk of substance abuse, results of a 10-year study suggest. full story

http://www.medpagetoday.com/Pediatrics/ADHD-ADD/dh/8548

CME SPOTLIGHT

Managing CardioMetabolic Complexities
You are invited to participate in the following free educational activity where you will learn about the interrelated factors contributing to the metabolic syndrome and novel therapeutic strategies aimed at attenuating cardiometabolic risk while delaying disease progression.
Source: SciMed New York [more]

Heart Failure: From Emergency Department to Discharge
Join Drs. Frank Michota and Charles Emerman, as they provide the evidence-based science to support physicians in making critical decisions about appropriate ADHF management. This interactive CME activity will review effective diagnosis and treatment strategies in the ED, during admission, and after discharge to prevent rehospitalizations and improve patient healthcare outcomes.
Source: Med-IQ [more]

Targeted Cancer Therapy From Trial To Clinic
Join Drs. Balducci, Atkins, Cantley, and Herbst for an innovative and in-depth CME-certified Activity on how integration of targeted and conventional therapies for treating cancer is improving patient outcomes.
Source: The Physicians Academy For Clinical and Management Excellence [more]

Waking Up to the Problem of OSA: Consequences and Improved Recognition
This neuroscienceCME VOICE activity will sharpen your awareness of OSA and arm you with screening tools and strategies to improve recognition and management, especially in populations that do not present with classic symptoms. Please register today.
Source: CME Outfitters [more]

neuroscienceCME Journal Club
Trouble keeping up with the latest findings from the clinical literature? neuroscienceCME Journal Club can help. Hear leading authors talk about just-published articles, and then answer your questions. Hosted by Thomas Roth, PhD.
Source: CME Outfitters [more]

Pathophysiology of Vasomotor Symptoms: Thermoregulatory and Cognitive Issues
This virtual symposium will help clinicians to better recognize factors contributing to the pathophysiology of vasomotor symptoms, and evaluate the latest data available to formulate patient-specific treatment plans.
Source: The Chatham Institute [more]

New phase 3 trials may dramatically alter the management of newly diagnosed myeloma.
This activity reviews these trials as well as new developments in transplantation and relapsed/refractory therapies.
Source: Curatio CME Institute [more]

The Science and Strategy of Biopreparedness: Critical Agent Update and Emerging Disease Threats
This activity employs an expert faculty to explore state-of-the-art knowledge about potential biological threats (Avian Influenza, Smallpox and Toxins), preventive measures and treatments currently available and on the horizon.
Source: Annenberg Center for Health Sciences at Eisenhower [more]

Age-and Race-Related Biological Characteristics of Breast Cancer
In this free CME/CE/CPE audio interview, Mark Pegram, MD, and Lisa A. Carey, MD, ScM, discuss the latest research on breast cancer tumor biology and its relation to age, race, and menopausal status. Listen online or download.
Source: Projects In Knowledge [more]

Emerging Patient Challenges in COPD: Interactive Case Simulator
Designed for primary care clinicians. This case-based CME activity provides a virtual learning experience, allowing participants to order diagnostic tests, prescribe drugs, diagnose and develop new treatment strategies; simulating clinical practice.
Source: CASIVUS [more]

Emerging Trends in the Treatment of Renal Cell Carcinoma
Drs. Michael B. Atkins, Bernard J. Escudier, and Gary R. Hudes lead this CME activity which examines current and evolving standards of care for the treatment of early stage and advanced renal cell carcinoma; best practices for optimal patient outcomes are also covered.
Source: The Physicians Academy For Clinical and Management Excellence [more]

Overview of Menopause: The Cycle of Vasomotor Disturbances
This virtual symposium will help clinicians who treat patients with vasomotor symptoms evaluate the latest data available to formulate patient-specific treatment plans, and will familiarize physicians with the need to communicate with their patients on alternative therapies and how those therapies may interact with prescription medications.
Source: The Chatham Institute [more]

RESOURCES

Now Approved: A new development in the treatment of hypertension.
Now approved from Forest Laboratories: Bystolic (nebivolol). A novel beta blocker for the treatment of hypertension. Click here to learn more. Source: Forest Labs [more]

Frequently painful. Potentially severe. Learn why your patients maybe be at risk.
Zoster: How Many of your patients are at risk? Source: Merck [more]

Explore the Possibilities in Type 2 Diabetes.
Explore the Possibilities in Type 2 Diabetes. Source: Merck [more]

Featured Job Opportunities from MedJobs Today

Surgery, Kentucky
Practice a full range of general surgery including endoscopies.
http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17439&refsrc=dh
Surgery, New Mexico
Work in a no trauma facility doing clinic and call coverage.
http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17582&refsrc=dh
General Surgery, Oregon
We will consider candidates Board Eligible within 5 years.
http://www.medjobstoday.com/seeker/job_detail.cfm?jobid=17652&refsrc=dh

Visit MedJobs Today.com to search for a new job!

ASCO GI Meeting

ASCO GI: Sunitinib Shows Good Real-World Imatinib-Resistant GIST Results

CHF

Statins Cut Death Rates in Heart Failure

Arthritis

Rituximab Meets Primary Endpoint as First-Line RA Biologic Therapy

General Nephrology

Surgical ICU Patients Benefit Most from Intensive Insulin

Get tools, resources & information about Gleevec matching the experience of attendees of the 2007 ASH Annual Meeting.

Did you miss the Gleevec booth at the 2007 ASH Meeting? Get tools, resources and information about Gleevec via a fully interactive virtual exhibit booth, matching the experience of attendees of the 2007 ASH Annual Meeting.

Source: Novartis Oncology.

At MedPage Today™, we’re PUTTING BREAKING MEDICAL NEWS INTO PRACTICE™.

You have received this email because you have registered to receive alert emails at www.medpagetoday.com, with the email address: delphine1939@videotron.ca. You can easily manage your subscriptions by clicking on the "Edit Profile" link below.

SUBSCRIBE OR UNSUBSCRIBE:
Edit Profile

TECHNICAL QUESTIONS:
webmaster@medpagetoday.com

MedPage Today, LLC.
Overlook at Great Notch
150 Clove Road
Little Falls, New Jersey 07424
Telephone: (973) 890-0985
Fax: (973) 890-1327